收藏切换
Review of the clinical trials for bispecific antibody and gene therapy treatments for hemophilia that have approved
收藏切换
PDF
Zi-qiao CHEN1, Xia CHEN2
Chinese Journal of Clinical Pharmacology | 2025, 41(1) : 137 - 142
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(1): 137-142
Review
Review of the clinical trials for bispecific antibody and gene therapy treatments for hemophilia that have approved
Full
Zi-qiao CHEN1, Xia CHEN2
Affiliations
  • 1.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
  • 2.Hangzhou Tigermed Consulting Co., Ltd, Hangzhou 310051, Zhejiang Province, China
Published: 2025-01-17 doi: 10.13699/j.cnki.1001-6821.2025.01.028
Outline
收藏切换

Hemophilia is a rare monogenic inherited coagulation factor deficiency disease, which begins in early childhood, and severe patients often have a history of spontaneous bleeding or joint muscle bleeding, requiring long-term frequent transfusion of clotting factor. This article reviews the clinical development process of bispecific antibody drug EMICIZUMAB and two gene therapies ROCTAVIAN and HEMGENIX for the corresponding hemophilia subtypes, so as to summarize the strategies for rare disease drug development and the key elements of gene therapy drug development, and to provide reference for the development of similar drugs in similar indications in the future.

bispecific antibody  /  hemophilia  /  gene therapy  /  clinical development
Zi-qiao CHEN, Xia CHEN. Review of the clinical trials for bispecific antibody and gene therapy treatments for hemophilia that have approved[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (1) : 137 -142 . DOI: 10.13699/j.cnki.1001-6821.2025.01.028
Year 2025 volume 41 Issue 1
PDF
2
1
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.01.028
  • Receive Date:2024-08-01
  • Online Date:2026-08-04
  • Published:2025-01-17
Article Data
Affiliations
History
  • Received:2024-08-01
Affiliations
    1.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, Jiangsu Province, China
    2.Hangzhou Tigermed Consulting Co., Ltd, Hangzhou 310051, Zhejiang Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.01.028
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT